Logo
  • Home
  • AI Agent
  • Annotations
  • Files
  • Pricing and plans
  • BlogAboutContact us
    APIMCP
    Terms of servicePrivacy policy
  • Get the full experience

    We save the real magic for signed-in users.

DOCS US​
HomeStock ScreenerDocument SearchChartingWatchlistsRecent Filings
Logo
  • Home
  • AI Agent
  • Annotations
  • Files
  • Pricing and plans
  • BlogAboutContact us
    APIMCP
    Terms of servicePrivacy policy
  • Get the full experience

    We save the real magic for signed-in users.

DOCS US​
HomeStock ScreenerDocument SearchChartingWatchlistsRecent Filings

Doximity, Inc. Class A(DOCS US)

$34.67+2.076.35%Ext:$34.59-0.080.22%(Pre-Market · 14:02:11 UTC)
ProfileFinancialsChartingShort InterestEmployees

Overview

Profile

Financials & Metrics

FinancialsChartingShort InterestEmployees

Doximity, Inc. Class A(DOCS US)

$34.67+2.076.35%Ext:$34.59-0.080.22%(Pre-Market · 14:02:11 UTC)
ProfileFinancialsChartingShort InterestEmployees

Overview

Profile

Financials & Metrics

FinancialsChartingShort InterestEmployees
Ask AI
Ask AI

Doximity, Inc. Class A — Company Profile

Doximity, Inc. provides a digital platform, hosted in the cloud, specifically designed for healthcare practitioners throughout the United States. This platform delivers a suite of specialized tools, empowering its members to connect with peers, streamline patient treatment, conduct remote consultations, access current medical information and research, and advance their professional careers. Its primary clientele consists of pharmaceutical companies and healthcare organizations. Established in 2010, the entity initially operated as 3MD Communications, Inc. before rebranding to Doximity, Inc. in June of that year. The company's corporate headquarters are situated in San Francisco, California.

Sector
Healthcare
Industry
Medical - Healthcare Information Services
Exchange
UN
CEO
Jeffrey A. Tangney
Headquarters
San Francisco, CA, US
IPO Date
Jun 24, 2021
Employees
880
Website
www.doximity.com

Key Metrics

Price
$27.93
Market Cap
$5.22B
Revenue (TTM)
$644.86M
Net Income (TTM)
$196.05M
EPS (TTM)
1.05
P/E (TTM)
26.64
P/B (TTM)
5.49
Dividend Yield
0.00%
ROE (TTM)
20.62%
ROA (TTM)
17.45%
Operating Margin
33.33%
Beta
0.67

Dividends

Last Dividend
$0.00
Last Yield
0.00%

Summary

Doximity, Inc. provides a digital platform, hosted in the cloud, specifically designed for healthcare practitioners throughout the United States. This platform delivers a suite of specialized tools, empowering its members to connect with peers, streamline patient treatment, conduct remote consultations, access current medical information and research, and advance their professional careers. Its primary clientele consists of pharmaceutical companies and healthcare organizations. Established in 2010, the entity initially operated as 3MD Communications, Inc. before rebranding to Doximity, Inc. in June of that year. The company's corporate headquarters are situated in San Francisco, California.

Website
www.doximity.com
Location
San Francisco, CA, US
Phone650 549 4330
Employees880
CEOJeffrey A. Tangney
SectorHealthcare
IndustryMedical - Healthcare Information Services
IPO DateJun 24, 2021

Ask AI

Company overview
Business model, segments, and competition.
Peer comparison
Metrics vs closest competitors.
Guidance & outlook
Forward guidance and assumptions.
Bull vs bear case
Upside drivers and key risks.
Valuation snapshot
Multiples vs history and peers.
Competitive moat
Defensibility and market position.
Management track record
Leadership and capital allocation history.
How it makes money
A short diagram of the business model.

Latest Documents

News

  • DOXIMITY, INC. (DOCS) SHAREHOLDER ALERT Bernstein Liebhard LLP Reminds Doximity, Inc. Investors of Upcoming Deadline08:35AM
  • Doximity, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - DOCS02:39AM
  • DOCS FINAL DEADLINE: ROSEN, A LEADING LAW FIRM, Encourages Doximity, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important November 16 Deadline in Securities Class Action - DOCS4 Nov
  • DEADLINE ALERT for Baidu, Inc. (BIDU), Doximity, Inc. (DOCS), and Better Home & Finance Holding Company (BETR): The Law Offices of Frank R. Cruz Reminds Investors of Lead Plaintiff Deadlines in Securities Fraud Class Actions4 Nov
  • DOCS Deadline Alert: Levi & Korsinsky Reminds Doximity, Inc. (DOCS) Investors of Securities Class Action Deadline on November 16, 20264 Nov
  • DOCS Investors Have Opportunity to Lead Doximity, Inc. Securities Fraud Lawsuit with SBS Law4 Nov
  • DOCS DEADLINE ALERT: ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Doximity, Inc. Investors to Secure Counsel Before Important November 16 Deadline in Securities Class Action - DOCS3 Nov
  • DOCS DEADLINE ALERT: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Doximity, Inc. Investors to Secure Counsel Before Important November 16 Deadline in Securities Class Action – DOCS3 Nov
  • INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Doximity, Inc. of Class Action Lawsuit and Upcoming Deadlines – DOCS3 Nov
  • DEADLINE ALERT for Doximity, Inc. (DOCS), Honeywell Aerospace, Inc. (HONA), and Bank Of America Corporation (BAC): The Law Offices of Howard G. Smith Reminds Investors of Opportunity to Lead Securities Fraud Class Actions3 Nov
  • DOCS UPCOMING DEADLINE: SueWallSt Alerts Doximity, Inc. Stockholders of Securities Class Action3 Nov
  • Curious about Doximity (DOCS) Q2 Performance? Explore Wall Street Estimates for Key Metrics3 Nov
  • Doximity, Inc. (NYSE: DOCS) SHAREHOLDER ALERT: Investors With Losses May Seek to Lead the Class Action in Doximity, Inc. Securities Lawsuit - Contact Portnoy Law Firm3 Nov
  • Doximity, Inc. Class Action Reminder - Robbin LLP Encouraged DOCS Investors to Contact the Firm for Information About Their Rights3 Nov
  • DOCS DEADLINE ALERT: ROSEN, A GLOBALLY RESPECTED LAW FIRM, Encourages Doximity, Inc. Investors to Secure Counsel Before Important November 16 Deadline in Securities Class Action - DOCS2 Nov
  • DOCS Deadline: DOCS Investors Have Opportunity to Lead Doximity, Inc. Securities Fraud Lawsuit2 Nov
  • Bragar Eagel & Squire, P.C. Urges Doximity, Inc. Investors to Contact the Firm Before November 16th Lead Plaintiff Deadline2 Nov
  • Deadline Alert: Doximity, Inc. Investors Have Until November 16, 2026 to Seek Lead Plaintiff Role in Securities Fraud Class Action, Glancy Prongay Wolke & Rotter LLP Reminds Investors2 Nov
  • Bronstein, Gewirtz & Grossman LLC Urges Doximity, Inc. Investors to Act: Class Action Filed Alleging Investor Harm2 Nov
  • DOCS Investors Have Opportunity to Lead Doximity, Inc. Securities Fraud Lawsuit with SBS Law2 Nov

Key Stats

Trading

Px/Chg 1D$27.93 / -2.00%
Avg Volume3.64M
Beta0.67
Mkt Cap5.22B
FD Mkt Cap5.00B

Float

Shrs Out/Float187.03M / 181.35M
Short Float0.11%
Days to Cover4.81
Stock Repurchased$431.65M

Current Valuation

EV5.01B
EV/EBITDA18.85
EV/Sales7.78
P/B5.49
P/S8.10
FCF Yield2.05%
ROE20.62%
ROA17.45%
Current Ratio6.09

Estimates

P/E26.64
Est P/E0.00
Est EPS0.28
Est PEG0.00

Valuation

Metric5Yr AvgAug '22Aug '23Aug '24Aug '25Oct '26
PRICE-BASED RATIOS
Price / Earnings117.9342.5858.9932.86175.31279.94
Price / Sales32.2519.1815.8810.2079.1836.81
Price / Book Value7.107.506.895.3810.115.63
Price / Free Cash Flow56.5854.5238.3727.20112.9049.88
ENTERPRISE VALUE METRICS
Enterprise Value6,730.46,478.36,512.54,767.110,752.35,141.8
Enterprise Value / Sales31.5118.8615.5410.0377.7535.37
Enterprise Value / EBITDA89.2854.6348.1026.18175.62141.83
Enterprise Value / EBIT96.2157.0652.0627.75184.13160.08

Financials

Full Financials
Millions USD5Yr CAGR (%)Mar '22Mar '23Mar '24Mar '25Mar '26
INCOME STATEMENT
Revenue17%343.5419.1475.4570.4644.9
Gross Income17.3%303.8365.6424.8514.5574.5
EBITDA22.2%118.6135.4182.1240.8264.4
EBIT21.8%113.5125.1171.8230.1250.0
Net Income6.1%154.8112.8147.6223.2196.1
EPS (Diluted)8.8%0.700.530.721.110.98
BALANCE SHEET
Cash & ST Inv-1.6%798.1841.0762.9915.7748.6
Total Assets3.2%991.41,136.91,079.41,264.31,123.7
Total Liabilities11.3%112.8170.8178.0181.7172.9
Total Shareholder Equity2%878.6966.1901.41,082.6950.8
CASH FLOW
Net Operating Cash Flow26.7%126.6179.6184.1273.3326.5
Cap Ex12%-5.7-6.2-5.8-6.5-9.0
Free Cash Flow27.3%120.9173.4178.3266.7317.5

Enterprise Value Bridge

Millions USD23 Oct '26
Price (As of 23 Oct '26)33.28
Basic Shares187.03
Market Cap6,224.2
Diluted Shares199.05
Fully Diluted Shares Outstanding199.05
Fully Diluted Market Cap6,624.3
+Consolidated Debt10.2
−In-the-Money Convertible Debt—
+Capital Leases8.1
+Operating Leases—
−Cash & Equivalents-219.2
−Short-term Investments-529.4
+Total Preferred-
−In-the-Money Convertible Preferred—
−Investments in Unconsolidated Subs—
+Non-Controlling Interest-
+Pension Liabilities—
Enterprise Value6,015.2

Segment data

Revenue

by Products and services

  • Subscription94%
  • Service, Other6%

Related companies

BrightSpring Health Services, Inc.

BTSG US

Pro Medicus Ltd./ADR

PMCUF US

Hinge Health, Inc.

HNGE US

Alibaba Health Information Technology Limited/ADR

ALBBY US

Heartflow, Inc.

HTFL US

Privia Health Group, Inc.

PRVA US

Winning Health Technology Group Co., Ltd.

300253 CS

JMDC Inc.

4483 JT

Indegene Limited

INDGN IB

Certara, Inc.

CERT US

Pennant Group, Inc.

PNTG US

U S Physical Therapy Inc /NV

USPH US

Doximity, Inc. Class A — Company Profile

Doximity, Inc. provides a digital platform, hosted in the cloud, specifically designed for healthcare practitioners throughout the United States. This platform delivers a suite of specialized tools, empowering its members to connect with peers, streamline patient treatment, conduct remote consultations, access current medical information and research, and advance their professional careers. Its primary clientele consists of pharmaceutical companies and healthcare organizations. Established in 2010, the entity initially operated as 3MD Communications, Inc. before rebranding to Doximity, Inc. in June of that year. The company's corporate headquarters are situated in San Francisco, California.

Sector
Healthcare
Industry
Medical - Healthcare Information Services
Exchange
UN
CEO
Jeffrey A. Tangney
Headquarters
San Francisco, CA, US
IPO Date
Jun 24, 2021
Employees
880
Website
www.doximity.com

Key Metrics

Price
$27.93
Market Cap
$5.22B
Revenue (TTM)
$644.86M
Net Income (TTM)
$196.05M
EPS (TTM)
1.05
P/E (TTM)
26.64
P/B (TTM)
5.49
Dividend Yield
0.00%
ROE (TTM)
20.62%
ROA (TTM)
17.45%
Operating Margin
33.33%
Beta
0.67

Dividends

Last Dividend
$0.00
Last Yield
0.00%

Summary

Doximity, Inc. provides a digital platform, hosted in the cloud, specifically designed for healthcare practitioners throughout the United States. This platform delivers a suite of specialized tools, empowering its members to connect with peers, streamline patient treatment, conduct remote consultations, access current medical information and research, and advance their professional careers. Its primary clientele consists of pharmaceutical companies and healthcare organizations. Established in 2010, the entity initially operated as 3MD Communications, Inc. before rebranding to Doximity, Inc. in June of that year. The company's corporate headquarters are situated in San Francisco, California.

Website
www.doximity.com
Location
San Francisco, CA, US
Phone650 549 4330
Employees880
CEOJeffrey A. Tangney
SectorHealthcare
IndustryMedical - Healthcare Information Services
IPO DateJun 24, 2021

Ask AI

Company overview
Business model, segments, and competition.
Peer comparison
Metrics vs closest competitors.
Guidance & outlook
Forward guidance and assumptions.
Bull vs bear case
Upside drivers and key risks.
Valuation snapshot
Multiples vs history and peers.
Competitive moat
Defensibility and market position.
Management track record
Leadership and capital allocation history.
How it makes money
A short diagram of the business model.

Latest Documents

News

  • DOXIMITY, INC. (DOCS) SHAREHOLDER ALERT Bernstein Liebhard LLP Reminds Doximity, Inc. Investors of Upcoming Deadline08:35AM
  • Doximity, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - DOCS02:39AM
  • DOCS FINAL DEADLINE: ROSEN, A LEADING LAW FIRM, Encourages Doximity, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important November 16 Deadline in Securities Class Action - DOCS4 Nov
  • DEADLINE ALERT for Baidu, Inc. (BIDU), Doximity, Inc. (DOCS), and Better Home & Finance Holding Company (BETR): The Law Offices of Frank R. Cruz Reminds Investors of Lead Plaintiff Deadlines in Securities Fraud Class Actions4 Nov
  • DOCS Deadline Alert: Levi & Korsinsky Reminds Doximity, Inc. (DOCS) Investors of Securities Class Action Deadline on November 16, 20264 Nov
  • DOCS Investors Have Opportunity to Lead Doximity, Inc. Securities Fraud Lawsuit with SBS Law4 Nov
  • DOCS DEADLINE ALERT: ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Doximity, Inc. Investors to Secure Counsel Before Important November 16 Deadline in Securities Class Action - DOCS3 Nov
  • DOCS DEADLINE ALERT: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Doximity, Inc. Investors to Secure Counsel Before Important November 16 Deadline in Securities Class Action – DOCS3 Nov
  • INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Doximity, Inc. of Class Action Lawsuit and Upcoming Deadlines – DOCS3 Nov
  • DEADLINE ALERT for Doximity, Inc. (DOCS), Honeywell Aerospace, Inc. (HONA), and Bank Of America Corporation (BAC): The Law Offices of Howard G. Smith Reminds Investors of Opportunity to Lead Securities Fraud Class Actions3 Nov
  • DOCS UPCOMING DEADLINE: SueWallSt Alerts Doximity, Inc. Stockholders of Securities Class Action3 Nov
  • Curious about Doximity (DOCS) Q2 Performance? Explore Wall Street Estimates for Key Metrics3 Nov
  • Doximity, Inc. (NYSE: DOCS) SHAREHOLDER ALERT: Investors With Losses May Seek to Lead the Class Action in Doximity, Inc. Securities Lawsuit - Contact Portnoy Law Firm3 Nov
  • Doximity, Inc. Class Action Reminder - Robbin LLP Encouraged DOCS Investors to Contact the Firm for Information About Their Rights3 Nov
  • DOCS DEADLINE ALERT: ROSEN, A GLOBALLY RESPECTED LAW FIRM, Encourages Doximity, Inc. Investors to Secure Counsel Before Important November 16 Deadline in Securities Class Action - DOCS2 Nov
  • DOCS Deadline: DOCS Investors Have Opportunity to Lead Doximity, Inc. Securities Fraud Lawsuit2 Nov
  • Bragar Eagel & Squire, P.C. Urges Doximity, Inc. Investors to Contact the Firm Before November 16th Lead Plaintiff Deadline2 Nov
  • Deadline Alert: Doximity, Inc. Investors Have Until November 16, 2026 to Seek Lead Plaintiff Role in Securities Fraud Class Action, Glancy Prongay Wolke & Rotter LLP Reminds Investors2 Nov
  • Bronstein, Gewirtz & Grossman LLC Urges Doximity, Inc. Investors to Act: Class Action Filed Alleging Investor Harm2 Nov
  • DOCS Investors Have Opportunity to Lead Doximity, Inc. Securities Fraud Lawsuit with SBS Law2 Nov

Key Stats

Trading

Px/Chg 1D$27.93 / -2.00%
Avg Volume3.64M
Beta0.67
Mkt Cap5.22B
FD Mkt Cap5.00B

Float

Shrs Out/Float187.03M / 181.35M
Short Float0.11%
Days to Cover4.81
Stock Repurchased$431.65M

Current Valuation

EV5.01B
EV/EBITDA18.85
EV/Sales7.78
P/B5.49
P/S8.10
FCF Yield2.05%
ROE20.62%
ROA17.45%
Current Ratio6.09

Estimates

P/E26.64
Est P/E0.00
Est EPS0.28
Est PEG0.00

Valuation

Metric5Yr AvgAug '22Aug '23Aug '24Aug '25Oct '26
PRICE-BASED RATIOS
Price / Earnings117.9342.5858.9932.86175.31279.94
Price / Sales32.2519.1815.8810.2079.1836.81
Price / Book Value7.107.506.895.3810.115.63
Price / Free Cash Flow56.5854.5238.3727.20112.9049.88
ENTERPRISE VALUE METRICS
Enterprise Value6,730.46,478.36,512.54,767.110,752.35,141.8
Enterprise Value / Sales31.5118.8615.5410.0377.7535.37
Enterprise Value / EBITDA89.2854.6348.1026.18175.62141.83
Enterprise Value / EBIT96.2157.0652.0627.75184.13160.08

Financials

Full Financials
Millions USD5Yr CAGR (%)Mar '22Mar '23Mar '24Mar '25Mar '26
INCOME STATEMENT
Revenue17%343.5419.1475.4570.4644.9
Gross Income17.3%303.8365.6424.8514.5574.5
EBITDA22.2%118.6135.4182.1240.8264.4
EBIT21.8%113.5125.1171.8230.1250.0
Net Income6.1%154.8112.8147.6223.2196.1
EPS (Diluted)8.8%0.700.530.721.110.98
BALANCE SHEET
Cash & ST Inv-1.6%798.1841.0762.9915.7748.6
Total Assets3.2%991.41,136.91,079.41,264.31,123.7
Total Liabilities11.3%112.8170.8178.0181.7172.9
Total Shareholder Equity2%878.6966.1901.41,082.6950.8
CASH FLOW
Net Operating Cash Flow26.7%126.6179.6184.1273.3326.5
Cap Ex12%-5.7-6.2-5.8-6.5-9.0
Free Cash Flow27.3%120.9173.4178.3266.7317.5

Enterprise Value Bridge

Millions USD23 Oct '26
Price (As of 23 Oct '26)33.28
Basic Shares187.03
Market Cap6,224.2
Diluted Shares199.05
Fully Diluted Shares Outstanding199.05
Fully Diluted Market Cap6,624.3
+Consolidated Debt10.2
−In-the-Money Convertible Debt—
+Capital Leases8.1
+Operating Leases—
−Cash & Equivalents-219.2
−Short-term Investments-529.4
+Total Preferred-
−In-the-Money Convertible Preferred—
−Investments in Unconsolidated Subs—
+Non-Controlling Interest-
+Pension Liabilities—
Enterprise Value6,015.2

Segment data

Revenue

by Products and services

  • Subscription94%
  • Service, Other6%

Related companies

BrightSpring Health Services, Inc.

BTSG US

Pro Medicus Ltd./ADR

PMCUF US

Hinge Health, Inc.

HNGE US

Alibaba Health Information Technology Limited/ADR

ALBBY US

Heartflow, Inc.

HTFL US

Privia Health Group, Inc.

PRVA US

Winning Health Technology Group Co., Ltd.

300253 CS

JMDC Inc.

4483 JT

Indegene Limited

INDGN IB

Certara, Inc.

CERT US

Pennant Group, Inc.

PNTG US

U S Physical Therapy Inc /NV

USPH US